Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 829-840 of 4,306
Drug study icon
Not recruitingISRCTN93636537

A multidisciplinary study of the management of neuroleptic medication in schizophrenia: Educational and collaborative approaches

This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
United Kingdom
Sponsor
Medical Research Council (MRC) (UK)
Condition
Schizophrenia
Drug study icon
Not recruitingISRCTN54567688

Acute effects of modafinil on cognitive function and activation of prefrontal cortex in people with schizophrenia

This study is looking at care and outcomes for people with Mental and Behavioural Disorders: Schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
United Kingdom
Sponsor
Department of Health (UK)
Condition
Schizophrenia
Drug study icon
Not recruitingISRCTN41543404

An international study of improving treatment for the most severely ill with schizophrenia

This study is looking at whether A double-blind, randomised controlled trial of risperidone compared to placebo augmentation will be carried out with 100 subjects can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in A double-blind, randomised controlled trial of risperidone compared to placebo augmentation will be carried out with 100 subjects and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
United Kingdom
Sponsor
Department of Health (UK)
Condition
Schizophrenia
Drug study icon
Not recruitingEUCTR 2020-003745-11

An open label, single arm, extension trial to examine long-term safety of BI 425809 once daily in patients with schizophrenia who have completed previous BI 425809 Phase III trials.(CONNEX-X)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

Multiple locations, including Vienna
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.
Countries
France, Belgium, Austria, ...
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
Other study type icon
Not recruitingISRCTN05808181

Brain imaging of the adenosine A2A receptor in schizophrenia

This study is looking at care and outcomes for people with Schizophrenia or Mental and Behavioural Disorders. Taking part may give some people access to Six un-medicated and six medicated subjects diagnosed with schizophrenia will be compared to six age-matched healthy volunteers, but direct benefit is not guaranteed.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
United Kingdom
Sponsor
King's College London (UK)
Condition
Schizophrenia
Other study type icon
Not recruitingISRCTN65536352

Cognitive Behavioural Case Management (CBCM) in First-Episode Schizophrenia and Related Psychotic Disorders - a study

This study is looking at whether [A] Cognitive Behavioural Case Management [B] Treatment-as-usual can help people with Mental and Behavioural Disorders: Schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in [A] Cognitive Behavioural Case Management [B] Treatment-as-usual and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
United Kingdom
Sponsor
Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Condition
Schizophrenia
Behavioral study icon
Not recruitingISRCTN55488371

Computerised Cognitive Remediation Therapy for Schizophrenia

This study is looking at whether a digital support tool can help people with psychosis. Participants take part in a digital support tool and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
United Kingdom
Sponsor
South London and Maudsley NHS Trust (UK)
Condition
Schizophrenia
Other study type icon
Not recruitingISRCTN51972256

Development and evaluation of personalised patient information for people with schizophrenia living in the community.

This study is looking at whether Randomised trial with three groups: 1 can help people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in Randomised trial with three groups: 1 and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
United Kingdom
Sponsor
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Condition
Schizophrenia
Behavioral study icon
Not recruitingISRCTN35852420

Neural correlates of response to COGnitive behaviour therapy in SCHIZophrenia: a functional magnetic resonance imaging investigation

This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
United Kingdom
Sponsor
King's College London (UK)
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.